← FDA DRUG APPROVALS

FDA ANDA · ANDA078133

CLOPIDOGREL BISULFATE

Sponsor: SUN PHARM INDUSTRIES

APPLICATION
ANDA078133
TYPE
ANDA
ORIGINAL APPROVAL
2013-06-10
LATEST ACTION
2020-05-19
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

CLOPIDOGREL BISULFATEDiscontinued
CLOPIDOGREL BISULFATE EQ 75MG BASE · TABLET · ORAL

Approval history

2020-05-19Labeling · Supplement 3 · standardAP
2020-05-19Labeling · Supplement 2 · standardAP
2016-08-09Labeling · Supplement 1 · standardAP
2013-06-10OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →